Literature DB >> 15915620

Clandestine drug laboratories in Australia and the potential for harm.

David G E Caldicott1, Paul E Pigou, Robert Beattie, John W Edwards.   

Abstract

The emphasis in the literature regarding illicit drugs has been overwhelmingly on the subject of harm caused by their ingestion. Little has been reported on the potential and real harm associated with the illicit manufacture of drugs. This paper describes the increasing prevalence of clandestine drug laboratories in Australia, overwhelmingly devoted to the manufacture of methamphetamine. The nature of the illicit synthetic process is reviewed together with its inherent dangers for the 'cook', first responders and bystanders including children, and the environment. We have analysed the emerging trends in manufacture and seizure in Australia, and offer suggestions to remedy significant deficiencies in knowledge and policy in the management of clandestine drug laboratories, especially with reference to clinical management issues, data collection, environmental contaminants and remediation, legislation and research. In particular, we conclude that: The problem of clandestine drug laboratories is growing in Australia, reflecting patterns world-wide. There are significant health and environmental implications of this growth. First responders should ensure that specialised expertise is available when decommissioning detected laboratories. Clinicians should familiarise themselves with the types of injuries associated with clandestine drug manufacture. Legislatures without a clandestine drug laboratory registry should establish one. Where it doesn't exist, legislation should be sought to curb the spread of this unwanted phenomenon. Significant opportunities exist for further research into the harm caused to first responders, the community, and the environment by clandestine laboratories.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15915620     DOI: 10.1111/j.1467-842x.2005.tb00066.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  5 in total

Review 1.  Management of clandestine drug laboratories: need for evidence-based environmental health policies.

Authors:  Tamara A Al-Obaidi; Stephanie M Fletcher
Journal:  Environ Health Prev Med       Date:  2013-09-04       Impact factor: 3.674

2.  Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine.

Authors:  Lisa McFadden; Bryan K Yamamoto; Leslie Matuszewich
Journal:  Behav Brain Res       Date:  2010-09-09       Impact factor: 3.332

3.  Injury associated with methamphetamine use: a review of the literature.

Authors:  Janie Sheridan; Sara Bennett; Carolyn Coggan; Amanda Wheeler; Karen McMillan
Journal:  Harm Reduct J       Date:  2006-03-29

4.  Evaluation of pseudoephedrine pharmacy sales before and after mandatory recording requirements in Western Australia: a case study.

Authors:  Hendrika Laetitia Hattingh; Janki Varsani; Leila Ataei Kachouei; Richard Parsons
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-08-30

5.  Application of a Microfluidic Gas-to-Liquid Interface for Extraction of Target Amphetamines and Precursors from Air Samples.

Authors:  Michael Collins; Murat Gel; Chris Lennard; Val Spikmans; Shari Forbes; Alisha Anderson
Journal:  Micromachines (Basel)       Date:  2020-03-17       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.